Darifenacin
CAS 133099-04-4
Em Estoque
Darifenacin
Cat. No. ANT-DRF-000CAS 133099-04-4Em Estoque
Dados Técnicos
Cat. No.ANT-DRF-000
CAS133099-04-4
Fórmula Mol.C28H30N2O2
Peso Mol.426.55 g/mol
IUPAC2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
SMILESC1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
InChIInChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1
Chave InChIHXGBXQDTNZMWGS-RUZDIDTESA-N
Pureza99%
Descrição
Visão geral
Darifenacin is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010, the US rights were sold to Warner Chilcott for US$400 million
A Anant Labs fabrica e fornece impurezas de Darifenacin de alta qualidade para o mercado global. Nossas impurezas EP de Darifenacin são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-alpha-alpha-diphenyl-3-pyrrolidineacetamideHydrobromideDarifenacin133099-04-42-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamideUK-88525darifenacineDarifenacinaDarifenacin extended releaseAPG9819VLMUK88525
